Multiplex Assays Market Research Report – Forecast to 2030

Multiplex Assays Market: By Products and Services (Consumables, Instruments), Types (Protein & Nucleic Acid Assay), Technology (Flow Cytometry & Other Technology), Application (Clinical Diagnostic), End-User (Hospital)- Forecast Till 2030

ID: MRFR/HC/4677-HCR | February 2023 | Region: Global | 90 Pages         

Multiplex Assays Market Speak to Analyst Request a Free Sample

Multiplex Assays Market

The Multiplex Assays Market is expected to grow USD 3.11 Billion at an approximate CAGR of 6.80 % during the forecast 2022-2030.

Segmentation
By Products and Services Consumables Instruments
By Types Protein Nucleic Acid Assay
By Technology Flow Cytometry Other Technology
By Application Clinical Diagnostic
Key Players
Companies Profiled   Thermo Fisher Scientific Inc   Illumina Inc   Bio-Rad Laboratories Inc   Qiagen   Abcam plc   BD   Merck Sharp & Dohme Corp   Agilent Technologies   Meso Scale Diagnostics LLC   Randox Laboratories Ltd   Quanterix
Drivers
Market Driving Forces   Technological advancement   Increasing awareness about the multifactorial nature of various diseases
Request a Free Sample

Multiplex Assays Market Scenario


The multiplex assays market is expected to reach USD 3.11 Billion an approximate CAGR of 6.80% during the forecast period (2022-2030). An assay which simultaneously measures multiple analysts in a single cycle is known as a multiplex assay. Technological advancement is one of the driving factors for the growth of this market. The rapid development in nanotechnology has taken this to the next level of nanoarray, which represents the ultra-miniaturization version of the conventional microarray. Increasing awareness about the multifactorial nature of various diseases and pathological conditions such as cancer and Alzheimer disease has created a requirement to produce a cost-effective and time-saving measurement of multiple analysts in a single sample. This factor drives the multiplex assays market.


Reproducibility crisis and complex clinical trial procedures for multiplex assay products are limiting the growth of the market.


Segmentation


The multiplex assays market is segmented on the basis of products and services, types, technology, application, and end-user. On the basis of products and services, the multiplex assays market is segmented into consumable, instrument, and software and services. Based on types, the market is segmented into protein, nucleic acid, and cell-based multiplex assay. Further, protein multiplex assay is sub-segmented into planer protein assay and bead-based protein assay. Nucleic acid multiplex assay is further sub-segmented into planer nucleic acid assay, bead-based nucleic acid assay, and other nucleic acid assay. On the basis of technology, the multiplex assay market is further segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, and other technologies. Further on the basis of application, the market is segmented into research and development, clinical diagnostic, and other diseases. Research and development is further sub-segmented into drug discovery and development, biomarker discovery, and validation. Clinical diagnostic is further sub-segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, and other diseases. Based on end-user, the market is segmented into pharmaceutical and biotechnology companies, hospital and research institutes, clinical laboratories, and other end-users.


Key players


Some of the key players in the multiplex assays market are Thermo Fisher Scientific Inc, Illumina Inc, Bio Rad Laboratories Inc, Qiagen, Abcam plc, BD, Merck Sharp & Dohme Corp, Agilent Technologies, Meso Scale Diagnostics LLC, Randox Laboratories Ltd,  Quanterix, Bio-Techne, and  Seegene Inc.


Regional Market Summary


Global Multiplex Assays Market Share (%), by Region, 2018


Multiplex Assay  Market Share


Sources: National Electronic Health Records Survey, U.S. Department of Health & Human Services, National Centre for Health Statistics


The multiplex assays market is divided into four major regions, namely, North America, Europe, Asia-Pacific, and the rest of the world. North America accounts for the largest share of the multiplex assays market owing to strong R&D activities in this region. The US is a leading country in biopharmaceutical research and development. The key factors that drive the growth of the market in this region are increase in patient population, the rise in the prevalence of Alzheimer disease, and a significant rise in research and development activities in pharmaceutical companies for the treatment of diseases such as cancer and Alzheimer.  


Asia-Pacific is expected to register the highest CAGR during the forecast period. Factors influencing the growth of this region include increasing geriatric population, rising prevalence of cataract, and increasing prevalence of Alzheimer disease in this region.


The European region is projected to register the highest CAGR during the forecast period due to increasing geriatric population included in system illness and chronic infection.


The Middle East and Africa holds the least share in the global multiplex assay market due to the presence of stringent government policies and poor economies.


Market Segmentation and Key Market Players


Multiplex Assays Market, by Products & Services



  • Consumable

  • Instrument

  • Software & Services


Multiplex Assays market, by Type



  • Protein multiplex assay

  • Planer protein assay

  • Bead-based protein assay

  • Nucleic acid multiplex assay

  • Planer nucleic acid assay

  • Bead-based nucleic acid assay

  • Other nucleic acid assay

  • Cell-based multiplex assay


Multiplex Assays Market, by Technology



  • Flow cytometry

  • Fluorescence detection

  • Luminescence

  • Multiplex real-time PCR

  • Other technology


Multiplex Assays Market, by Application



  • Research & development

  • Drug discovery & development

  • Biomarker discovery & validation

  • Clinical diagnostic

  • Infectious disease

  • Cancer

  • Cardiovascular disease

  • Autoimmune disease

  • Nervous system disorders

  • Other diseases


Multiplex Assays Market, by End-User



  • Pharmaceutical and biotechnology companies

  • Hospitals

  • Research institutes

  • Clinical laboratories

  • Other end-users


Multiplex Assays Market, by Region



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa


Multiplex Assays Market, by Key Players



  • Thermo Fisher Scientific Inc

  • Illumina Inc

  • Bio-Rad Laboratories Inc

  • Qiagen

  • Abcam plc

  • BD

  • Merck Sharp & Dohme Corp

  • Agilent Technologies

  • Meso Scale Diagnostics LLC

  • Randox Laboratories Ltd

  • Quanterix,

  • Bio-Techne

  • Seegene Inc.


Intended Audience



  • Biotechnology company

  • Pharmaceutical company

  • Government & private laboratories

  • Research & development companies

  • Medical research laboratories



Report Scope:

Report Attribute/Metric Details
  Market Size   2030: USD 3.11 Billion
  CAGR   6.80% (2022-2030)
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Products and Services, Types, Technology, Application and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Thermo Fisher Scientific Inc, Illumina Inc, Bio Rad Laboratories Inc, Qiagen, Abcam plc, BD, Merck Sharp & Dohme Corp, Agilent Technologies, Meso Scale Diagnostics LLC, Randox Laboratories Ltd, Quanterix, Bio-Techne, and Seegene Inc.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Technological advancement
  • Increasing awareness about the multifactorial nature of various diseases


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The Multiplex Assays Market can expand at 6.80% CAGR by 2030.

    Thermo Fisher Scientific Inc,Illumina Inc,Bio-Rad Laboratories Inc,Qiagen,Abcam plc,BD,Merck Sharp & Dohme Corp,Agilent Technologies,Meso Scale Diagnostics LLC,Randox Laboratories Ltd,Quanterix,,Bio-Techne,Seegene Inc. are key players of the Multiplex Assays Market

    The Multiplex Assays Market value can exceed USD 3.11 Billion by 2030.

    rise in the prevalence of Alzheimer disease

    North America is expected to be highly lucrative region